BeiGene (NasdaqGS:ONC) has climbed 32% over the past quarter, against a backdrop of significant industry challenges and broad market declines. The company's positive momentum can be attributed to the ...

Shanghai's RiboX Therapeutics begins first-ever circular RNA clinical trial, targeting dry mouth in cancer patients. Company ...

The Cambridge, MA-based biotech is letting go of about 70 employees, a spokesperson confirmed to Endpoints News on Friday ...

ImmunityBio, Inc.'s advances with Anktiva & rBCG show promise amid financial hurdles. Click here to find out why IBRX stock ...

Latest data shows the largest indicative borrow rate increases among liquid option names include: SES AI Corp (SES) 118.91% +9.28, Microvision ...

Teacher Retirement System of Texas grew its stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 20.4% in the ...

D. Boral Capital reaffirmed their buy rating on shares of ImmunityBio (NASDAQ:IBRX – Free Report) in a report issued on Monday,Benzinga reports. They currently have a $30.00 target price on the stock.

We recently published a list of 10 Stocks Outperform Broader Market Last Week. In this article, we are going to take a look ...

ImmunityBio, Inc.’s IBRX share price has surged by 20.86%, which has investors questioning if this is right time to sell.

ImmunityBio, Inc. , a leading immunotherapy company, invites current and prospective investors to its Investor Day program to be held on Tuesday, April 15, 2025, at 10:00 am PDT. The program will ...

DNA Payments, a leading independent, full-service omnichannel payments provider, will be exhibiting at the Retail Technology Show, taking place at ExCeL, London on the 2nd and 3rd of April 2025. This ...

We recently published a list of Top 10 Penny Stocks That Will Skyrocket. In this article, we are going to take a look at ...